CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Pharmacoeconomic analysis of antihypertensive drugs and evaluation of quality of life, an observational study in patients with hypertension, GGH, Anantapuramu

Author: 
Dr. Sowmya, B., Dr. Srujani, J., Dr. Shantha Bai, K., Dr. Srinivasa Rao, R., Dr. A. Anitha and Dr. Mahendranath, Y.
Subject Area: 
Health Sciences
Abstract: 

Introduction: Hypertension is one of the leading cause of global burden of disease and as it is a chronic condition with significant detrimental effects on the wide range of health outcomes, cost effective management of hypertension a appears to be a great challenge for both developed as well as developing countries eventhough recently there have been lot of studies on pharmaco- economics and out come research in the field of hypertension globally, but the results cannot be exactly extrapolated to Indian scenario as the economic status and socio economics factors are different in India as compared to the countries. Hence a study was undertaken to evaluate the cost effectiveness of antihypertensive drugs in our hospital. Objectives: To evaluate the prescription pattern, cost effective antihypertensive therapy and quality of (QoL) of the patients. Materials and Methods: An observational comparative study is planned on 100 patients Attending the outpatient Department of General medicine at GGH, Ananthapuramu from JUNE 2018 to DECEMBER 2018 with a follow up period of 6 months. Written informed consent is obtained from all the patients satisfying the inclusion criteria. In first visit, a detailed history is taken regarding the disease (hypertension) duration, co morbid condition, socio economic status, duration of antihypertensive therapy. Blood pressure and pulse is recorded, drug therapy details noted like pattern (monotherapy or multi drug therapy), costs of the drugs, dosage of the drug and changes in the drug therapy. After 6 months, again same details are collected. The details so obtained regarding the different patterns of drug therapy are analysed for the cost effectiveness. Statistical tests used for analysis are Chi square Test and “T” test. The QoL is evaluated with SF – 30 questionnaire. Results: Multitherapy was frequently prescribed (74%), out of that Atenolol with amlodipine. combination was most common (54%) , Diabetes was the most common co- morbid condition (24%). In mono therapy Amlodipine proved to be more cost effective (CER of 8.93) then Atenolol (CER 18.15) (p-0.0059) and in multitherapy Amlodipine with Enalapril combination was more cost effective *CER 18.24) then Amlodipine with Atenolol (CER 27.73) with (p-0.057). Conclusion: Multitherapy was most frequently prescribed, and Amlodipine with Enalapril combination proved to be most cost effective therapy. HRQoL was not much different in all the treatment groups.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran